Stamford -- Curaleaf Holdings says its enhanced premium offer of October 6, 2026 for all outstanding Aurora Cannabis common shares remains open, after Aurora announced an alternative transaction with Organigram Global.

STAMFORD – November 03, 2026 -- Curaleaf Holdings reported record third-quarter net revenue of $352.7 million, up 10.9% from $317.9 million a year earlier, as its international segment grew 28% and its domestic business grew 8%. Sequentially, revenue rose 3.6% from $340.1 million in the second quarter of 2026.

Edmonton – October 14, 2026 -- Aurora Cannabis' board unanimously recommended that shareholders reject Curaleaf Holdings' revised hostile offer, which remains open until December 4, 2026, and said its special committee is actively exploring alternatives, including a deal with one or more third parties.

Stamford, Conn. – – September 11, 2026 -- Curaleaf Holdings, Inc. released a fact sheet countering what it called inaccurate statements by Aurora Cannabis Inc. regarding Curaleaf's proposal to acquire the company, arguing its offer represents one of the highest premiums in a decade of Canadian M&A.